Biomednewsbreaks - Annovis Bio Inc. (NYSE: ANVS) Committed To Ensuring Highest Standards In Continued Buntanetap Trials
(MENAFN- Investor Brand Network) Annovis Bio (NYSE: ANVS) is a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases. The company's lead candidate, buntanetap, is an innovative drug that targets multiple …